Executive Briefing – Brazil emerges as a saviour for pharma
This article was originally published in Scrip
Executive Summary
Big pharma companies need to expand in fast-growing, emerging markets to offset declining returns on investment in developed countries. As the second largest emerging pharmaceutical market after China, and among the world's top 10 pharmaceutical markets overall, Brazil offers huge potential for companies to expand, writes Sita Shah.